GoodRx Holdings, Inc. (GDRX) News

GoodRx Holdings, Inc. (GDRX): $4.48

0.02 (+0.45%)

POWR Rating

Component Grades













Filter GDRX News Items

GDRX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

GDRX News Highlights

  • For GDRX, its 30 day story count is now at 22.
  • Over the past 27 days, the trend for GDRX's stories per day has been choppy and unclear. It has oscillated between 1 and 6.
  • BEAT, DOUG and DRUG are the most mentioned tickers in articles about GDRX.

Latest GDRX News From Around the Web

Below are the latest news stories about GOODRX HOLDINGS INC that investors may wish to consider to help them evaluate GDRX as an investment opportunity.

How Can I Save Money on My Prescriptions?

Americans are struggling to cover the costs of prescription drugs. According to a survey published in October by, four in 10 prescription medication users fear that prescription drug...

Yahoo | November 28, 2022

Why Shares of GoodRx Holdings Fell 18.7% Lower This Week

Shares of GoodRx Holdings (NASDAQ: GDRX) are down 27.8% this week, according to data from S&P Global Market Intelligence. The digital platform company looks to reduce the costs of prescription drugs to consumers.

Yahoo | November 18, 2022

2 Growth Stocks Down More Than 50% From Their Highs That Could Be Hot Buys for 2023

Shares of GoodRx Holdings (NASDAQ: GDRX) and Netflix (NASDAQ: NFLX) are both down more than 50% off their highs. GoodRx is a business I could see doing well amid a downturn in the economy next year, even as inflation continues to rise.

Yahoo | November 16, 2022

These Analysts Just Made An Downgrade To Their GoodRx Holdings, Inc. (NASDAQ:GDRX) EPS Forecasts

Market forces rained on the parade of GoodRx Holdings, Inc. ( NASDAQ:GDRX ) shareholders today, when the analysts...

Yahoo | November 16, 2022

Wall Street Analysts Think GoodRx Holdings, Inc. (GDRX) Could Surge 97%: Read This Before Placing a Bet

The consensus price target hints at a 97.4% upside potential for GoodRx Holdings, Inc. (GDRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Yahoo | November 15, 2022

Can Doximity Stock Keep On Climbing?

A positive earnings report recently pushed Doximity through the roof, but Investors want to know whether the stock can deliver long-term gains.

Yahoo | November 15, 2022

GoodRx Holdings Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags

GoodRx Holdings ( NASDAQ:GDRX ) Third Quarter 2022 Results Key Financial Results Revenue: US$187.3m (down 4.0% from 3Q...

Yahoo | November 11, 2022

Robinhood, MicroStrategy And Other Big Losers From Wednesday

U.S. stocks closed lower on Wednesday, with the Dow Jones dipping more than 600 points. Here is the list of some big stocks recording losses in the previous session. Chart Industries, Inc. (NYSE: GTLS ) fell 35.6% to close at $154.31 after the company announced it will acquire Howden for $4.4 billion in cash and stock. LifeStance Health Group, Inc. (NASDAQ: LFST ) declined 28.9% to settle at $5.09 after the company issued Q4 and FY22 guidance below estimates. Affirm Holdings, Inc. (NASDAQ: AFRM ) fell 22.6% to close at $12.10 after the company reported weaker-than-expected Q1 earnings and issued FY23 sales guidance below analyst estimates. GoodRx Holdings, Inc. (NASDAQ: GDRX ) dropped 22.5% to close at $4.06 after the company issued Q4 sales guidance below analyst estimates. Roblox Corp...

Benzinga | November 10, 2022

GDRX or LHCG: Which Is the Better Value Stock Right Now?

GDRX vs. LHCG: Which Stock Is the Better Value Option?

Yahoo | November 10, 2022

Analysts Have Conflicting Sentiments on These Technology Companies: 2U (TWOU), GoodRx Holdings (GDRX) and Squarespace (SQSP)

Analysts have been eager to weigh in on the Technology sector with new ratings on 2U (TWOU – Research Report), GoodRx Holdings (GDRX – Research Report) and Squarespace (SQSP – Research Report). 2U (TWOU) In a report released today, Jeffrey Silber from BMO Capital maintained a Buy rating on 2U, with a price target of $9.00. The company's shares closed last Wednesday at $6.21, close to its 52-week low of $4.70. According to, Silber is a 5-star analyst with an average return of -6.2% and a 42.7% success rate. Dodge covers the Technology sector, focusing on stocks such as Tabula Rasa HealthCare, NextGen Healthcare, and Thorne HealthTech.

Howard Kim on TipRanks | November 9, 2022

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7378 seconds.